This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
To the Editor:
—This letter is written to urge physicians and medical societies, individually and collectively, to exert all the influence they can bring to bear on Congress to abolish the patents on salvarsan, which, aside from causing enormous expense to the sick, have put very serious restrictions on the use of this necessary drug.Now is the best opportunity we shall ever have to get rid of these patents. Our experience with salvarsan during the last two years has been almost intolerable. Salvarsan and its related products, during this time, have been obtainable only through the grace of one man, Mr. H. A. Metz, in New York City. The drug is covered, we understand, by all the protective privileges that can possibly be used in caring for the pecuniary interests of those owning proprietary remedies. The name is copyrighted; the drug itself is a patented product; and the processes
Vanderslice JW, Walsh JH, Pusey WA, Engman MF, Burford CE, Lyter JC. ABOLITION OF THE PATENTS ON SALVARSAN. JAMA. 1917;LXVIII(16):1203–1204. doi:10.1001/jama.1917.04270040191022
Customize your JAMA Network experience by selecting one or more topics from the list below.